Abstract
Background: COVID-19 has superseded all medical scientific challenges in 2020. It presented with a range of respiratory involvement from the mild upper respiratory tract to severe pneumonia with ARDS. A percentage of these patients manifested variable neurological presentations expanding the challenges of patients’ assessment, care, and management.
 Objective: To discuss the neurological manifestations and the possible immunopathology of COVID-19.
 Methods: A literature search was performed in the PubMed database for the relevant articles published in English language between April 9th , 2020 and June 1, 2020. Few papers were extracted from Google Scholar and pre-print material as well. The keywords used to perform search included “COVID-19,” “SARS Cov2,” “neurological manifestations,” and “immunology and pathology of COVID-19”. However, animal studies were excluded in the neurological manifestations, and the final number of literature search outcome was 27 articles.
 Results: The immunopathology involves angiotensin-converting enzyme (ACE) receptor 2 and spike protein S1. COVID-19 has a tremendous affinity to the ACE2 receptor. The status of secondary hemophagocytic lymphohistiocytosis (sHLH) and the cytokine storm lead to different organ damage and the corresponding clinical manifestations. The documented neurological manifestations mainly include acute ischemic stroke, hemorrhagic stroke, temporal lobe, thalamic encephalitis, and one case of Guillain-Barre Syndrome, in addition to agitation, headache, and seizures.
 Conclusion: Although the intimate relationship between the neurons and the immune activation is the basic concept of COVID-19 immunopathology, the definite routes of entry to the neuronal cells are yet to be disclosed. Acute stroke, myositis, headache, and meningoencephalitis are the most common types of complications of COVID-19 so far.
Highlights
COVID-19, which caused a global lockdown in 2020, exerts a major health and economic challenge
Since Guillain-Barre Syndrome (GBS) is an autoimmune disease and molecular mimicry is the main immunopathological mechanism in its etiology, we find it difficult to confirm this case given the lack of Cerebrospinal fluid (CSF) and autoantibodies result
The extreme immunological storm caused by the virus results in a secondary hemophagocytic lymphohistiocytosis ending with serious pathological damage to the lungs, brain, muscles, and kidneys
Summary
COVID-19, which caused a global lockdown in 2020, exerts a major health and economic challenge. The WHO initially named it as SARS-CoV-2, which was later changed to COVID-19 Both viruses share the same receptors to enter the cells that are the angiotensin-converting enzyme 2 receptor [1]. The brain expresses a metallopeptidase, ACE2 receptors in the glial cells and neurons This can make the neurons a possible goal for COVID-19 virus [2, 3]. The objective of this review was to discuss the neurological manifestations and the possible related immunopathology of COVID-19. COVID-19 has superseded all medical scientific challenges in 2020 It presented with a range of respiratory involvement from the mild upper respiratory tract to severe pneumonia with ARDS. Objective: To discuss the neurological manifestations and the possible immunopathology of COVID-19. Myositis, headache, and meningoencephalitis are the most common types of complications of COVID-19 so far
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
